Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710283019 | Hydralazine- and isosorbide-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710284013 | Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4648351000052110 | läkemedel som innehåller hydralazin och isosorbid, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydralazine- and isosorbide-containing product in oral dose form | Is a | Hydralazine-containing product in oral dose form | true | Inferred relationship | Some | ||
| Hydralazine- and isosorbide-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Hydralazine- and isosorbide-containing product in oral dose form | Is a | Product containing isosorbide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Hydralazine- and isosorbide-containing product in oral dose form | Is a | Product containing hydralazine and isosorbide (medicinal product) | true | Inferred relationship | Some | ||
| Hydralazine- and isosorbide-containing product in oral dose form | Has active ingredient | Isosorbide (substance) | true | Inferred relationship | Some | 1 | |
| Hydralazine- and isosorbide-containing product in oral dose form | Has active ingredient | Hydralazine (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| hydralazin 37,5 milligram och isosorbiddinitrat 20 milligram, oral tablett | Is a | False | Hydralazine- and isosorbide-containing product in oral dose form | Inferred relationship | Some | |
| Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) | Is a | True | Hydralazine- and isosorbide-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR